CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C26804 | BRD-K76656279 | BRD-K76656279 | -- | -- | -- | Details |
| C26805 | BRD-K76661445 | BRD-K76661445 | -- | -- | -- | Details |
| C26806 | BRD-K76662562 | BRD-K76662562 | -- | -- | -- | Details |
| C26807 | BRD-K76664579 | BRD-K76664579 | -- | -- | -- | Details |
| C26808 | BRD-K76665419 | BRD-K76665419 | -- | -- | -- | Details |
| C26809 | BRD-K76665741 | BRD-K76665741 | -- | -- | -- | Details |
| C26810 | BRD-K76672145 | BRD-K76672145 | -- | -- | -- | Details |
| C26811 | BRD-K76672835 | BRD-K76672835 | -- | -- | -- | Details |
| C26812 | BRD-K76674262 | BRD-K76674262 | -- | -- | homoharringtonine | Details |
| C26813 | BRD-K76677554 | BRD-K76677554 | -- | -- | A-J76-(+) | Details |
| C26814 | BRD-K76680796 | BRD-K76680796 | -- | -- | -- | Details |
| C26815 | BRD-K76688030 | BRD-K76688030 | -- | -- | -- | Details |
| C26816 | BRD-K76688164 | BRD-K76688164 | -- | -- | -- | Details |
| C26817 | BRD-K76688397 | BRD-K76688397 | -- | -- | -- | Details |
| C26818 | BRD-K76688996 | BRD-K76688996 | -- | -- | -- | Details |
| C26819 | BRD-K76691125 | BRD-K76691125 | -- | -- | -- | Details |
| C26820 | BRD-K76691746 | BRD-K76691746 | -- | -- | -- | Details |
| C26821 | BRD-K76694128 | rebastinib | FLT3; ABL1; KDR; BCR; TEK | VEGFR inhibitor; Abl kinase inhibitor; TIE tyrosine kinase inhibitor | -- | Details |
| C26822 | BRD-K76698671 | HNHA | HDAC1 | HDAC inhibitor | hnha | Details |
| C26823 | BRD-K76701247 | BRD-K76701247 | -- | -- | -- | Details |
| C26824 | BRD-K76703230 | YM-155 | BIRC5 | Survivin inhibitor | -- | Details |
| C26825 | BRD-K76703685 | BRD-K76703685 | -- | -- | -- | Details |
| C26826 | BRD-K76706127 | BRD-K76706127 | -- | -- | -- | Details |
| C26827 | BRD-K76710817 | BRD-K76710817 | -- | -- | -- | Details |
| C26828 | BRD-K76712687 | BRD-K76712687 | -- | -- | -- | Details |
| C26829 | BRD-K76713298 | BRD-K76713298 | -- | -- | -- | Details |
| C26830 | BRD-K76713927 | BRD-K76713927 | -- | -- | -- | Details |
| C26831 | BRD-K76718418 | BRD-K76718418 | -- | -- | -- | Details |
| C26832 | BRD-K76719364 | GS-9973 | SYK | Syk inhibitor | -- | Details |
| C26833 | BRD-K76723084 | isotretinoin | RARA; RARB; RARG | Retinoid receptor agonist | -- | Details |
| C26834 | BRD-K76723780 | BRD-K76723780 | -- | -- | -- | Details |
| C26835 | BRD-K76729250 | BRD-K76729250 | -- | -- | -- | Details |
| C26836 | BRD-K76729384 | BRD-K76729384 | -- | -- | -- | Details |
| C26837 | BRD-K76732672 | BRD-K76732672 | -- | -- | -- | Details |
| C26838 | BRD-K76734722 | BRD-K76734722 | -- | -- | -- | Details |
| C26839 | BRD-K76738405 | BRD-K76738405 | -- | -- | -- | Details |
| C26840 | BRD-K76742876 | BRD-K76742876 | -- | -- | -- | Details |
| C26841 | BRD-K76747609 | beclometasone | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
| C26842 | BRD-K76748254 | BRD-K76748254 | -- | -- | -- | Details |
| C26843 | BRD-K76749891 | BRD-K76749891 | -- | -- | -- | Details |
| C26844 | BRD-K76755163 | BRD-K76755163 | -- | -- | -- | Details |
| C26845 | BRD-K76755209 | BRD-K76755209 | -- | -- | -- | Details |
| C26846 | BRD-K76758536 | BRD-K76758536 | -- | -- | -- | Details |
| C26847 | BRD-K76763044 | BRD-K76763044 | -- | -- | -- | Details |
| C26848 | BRD-K76764002 | BRD-K76764002 | -- | -- | -- | Details |
| C26849 | BRD-K76765843 | BRD-K76765843 | -- | -- | -- | Details |
| C26850 | BRD-K76772814 | BRD-K76772814 | -- | -- | -- | Details |
| C26851 | BRD-K76773351 | AS-605240 | PIK3CG | PI3K inhibitor | -- | Details |
| C26852 | BRD-K76775527 | nimesulide | LTF; PTGS2 | Cyclooxygenase inhibitor | -- | Details |
| C26853 | BRD-K76779710 | BRD-K76779710 | -- | -- | -- | Details |
| C26854 | BRD-K76784707 | BRD-K76784707 | -- | -- | -- | Details |
| C26855 | BRD-K76786157 | BRD-K76786157 | -- | -- | -- | Details |
| C26856 | BRD-K76788397 | BRD-K76788397 | -- | -- | -- | Details |
| C26857 | BRD-K76803075 | BRD-K76803075 | -- | -- | -- | Details |
| C26858 | BRD-K76805682 | SB-415286 | GSK3B | GSK-3 inhibitor | -- | Details |
| C26859 | BRD-K76810206 | nicergoline | ADRA1A | Adrenergic receptor antagonist | -- | Details |
| C26860 | BRD-K76811126 | BRD-K76811126 | -- | -- | -- | Details |
| C26861 | BRD-K76812105 | BRD-K76812105 | -- | -- | -- | Details |
| C26862 | BRD-K76812510 | metamizole | PTGS1 | Opioid receptor agonist; Cyclooxygenase inhibitor | -- | Details |
| C26863 | BRD-K76812993 | BRD-K76812993 | -- | -- | -- | Details |
| C26864 | BRD-K76820571 | BRD-K76820571 | -- | -- | -- | Details |
| C26865 | BRD-K76824416 | BRD-K76824416 | -- | -- | -- | Details |
| C26866 | BRD-K76825413 | BRD-K76825413 | -- | -- | -- | Details |
| C26867 | BRD-K76829357 | BRD-K76829357 | -- | -- | -- | Details |
| C26868 | BRD-K76833108 | BRD-K76833108 | -- | -- | -- | Details |
| C26869 | BRD-K76836103 | BRD-K76836103 | -- | -- | -- | Details |
| C26870 | BRD-K76840893 | RS-17053 | ADRA1A | Adrenergic receptor antagonist | -- | Details |
| C26871 | BRD-K76841105 | tazarotene | RARA; RARB; RARG | Retinoid receptor agonist | -- | Details |
| C26872 | BRD-K76845197 | sulfanitran | -- | -- | -- | Details |
| C26873 | BRD-K76846644 | BRD-K76846644 | -- | -- | -- | Details |
| C26874 | BRD-K76850979 | BRD-K76850979 | -- | -- | -- | Details |
| C26875 | BRD-K76856691 | BRD-K76856691 | -- | -- | -- | Details |
| C26876 | BRD-K76859558 | BRD-K76859558 | -- | -- | -- | Details |
| C26877 | BRD-K76861469 | BRD-K76861469 | -- | -- | -- | Details |
| C26878 | BRD-K76872913 | benzanthrone | -- | -- | -- | Details |
| C26879 | BRD-K76876037 | BRD-K76876037 | -- | -- | -- | Details |
| C26880 | BRD-K76880231 | BRD-K76880231 | -- | -- | -- | Details |
| C26881 | BRD-K76882095 | BRD-K76882095 | -- | -- | -- | Details |
| C26882 | BRD-K76882503 | BRD-K76882503 | -- | -- | -- | Details |
| C26883 | BRD-K76882924 | BRD-K76882924 | -- | -- | -- | Details |
| C26884 | BRD-K76885311 | BRD-K76885311 | -- | -- | -- | Details |
| C26885 | BRD-K76885481 | BRD-K76885481 | -- | -- | -- | Details |
| C26886 | BRD-K76889263 | BRD-K76889263 | -- | -- | -- | Details |
| C26887 | BRD-K76892938 | BRD-K76892938 | -- | -- | -- | Details |
| C26888 | BRD-K76893182 | BRD-K76893182 | -- | -- | -- | Details |
| C26889 | BRD-K76893224 | BRD-K76893224 | -- | -- | -- | Details |
| C26890 | BRD-K76893279 | BRD-K76893279 | -- | -- | -- | Details |
| C26891 | BRD-K76894938 | CHIR-99021 | -- | -- | -- | Details |
| C26892 | BRD-K76896049 | BRD-K76896049 | -- | -- | -- | Details |
| C26893 | BRD-K76896099 | BRD-K76896099 | -- | -- | -- | Details |
| C26894 | BRD-K76896292 | BRD-K76896292 | -- | -- | -- | Details |
| C26895 | BRD-K76899562 | BRD-K76899562 | -- | -- | -- | Details |
| C26896 | BRD-K76900919 | BRD-K76900919 | -- | -- | -- | Details |
| C26897 | BRD-K76904146 | BRD-K76904146 | -- | -- | -- | Details |
| C26898 | BRD-K76904668 | BRD-K76904668 | -- | -- | -- | Details |
| C26899 | BRD-K76907295 | VU-0418947-2 | -- | -- | -- | Details |
| C26900 | BRD-K76908866 | CP-724714 | ERBB2 | EGFR inhibitor; Tyrosine kinase inhibitor | -- | Details |
| C26901 | BRD-K76909981 | BRD-K76909981 | -- | -- | -- | Details |
| C26902 | BRD-K76910883 | BRD-K76910883 | -- | -- | -- | Details |
| C26903 | BRD-K76915833 | BRD-K76915833 | -- | -- | -- | Details |